IMAGE: A patient being treated for Hepatitis in a Gujarat hospital. Photograph: Amit Dave/Reuters The silent epidemic is playing havoc with the lives of millions of Indians. But those suffering......
Bristol-Myers Squibb India, the wholly owned subsidiary of the $19.2 billion US pharmaceutical company, has launched Baraclude, its anti-Hepatitis B drug in India.Baraclude, an entecavir oral......